A detailed history of American Century Companies Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, American Century Companies Inc holds 378,307 shares of AZN stock, worth $25.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
378,307
Previous 520,223 27.28%
Holding current value
$25.1 Million
Previous $40.6 Million 27.35%
% of portfolio
0.02%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$76.67 - $87.62 $10.9 Million - $12.4 Million
-141,916 Reduced 27.28%
378,307 $29.5 Million
Q2 2024

Aug 07, 2024

SELL
$66.81 - $80.83 $21.9 Million - $26.5 Million
-327,510 Reduced 38.63%
520,223 $40.6 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $3.33 Million - $3.79 Million
54,520 Added 6.87%
847,733 $57.4 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $49.1 Million - $55 Million
793,213 New
793,213 $53.4 Million
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $6.61 Million - $7.31 Million
-101,899 Reduced 12.27%
728,546 $49.3 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $10.4 Million - $11.2 Million
-148,278 Reduced 15.15%
830,445 $59.4 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $15.3 Million - $17.4 Million
242,344 Added 32.91%
978,723 $67.9 Million
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $23.1 Million - $30 Million
-425,524 Reduced 36.62%
736,379 $49.9 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $104,555 - $267,699
1,972 Added 0.17%
1,161,903 $63.7 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $388,567 - $466,464
6,557 Added 0.57%
1,159,931 $76.6 Million
Q1 2022

May 11, 2022

SELL
$55.72 - $67.12 $15.3 Million - $18.4 Million
-273,757 Reduced 19.18%
1,153,374 $76.5 Million
Q4 2021

Feb 07, 2022

BUY
$54.02 - $63.83 $6.49 Million - $7.67 Million
120,193 Added 9.2%
1,427,131 $83.1 Million
Q3 2021

Nov 10, 2021

BUY
$55.56 - $60.79 $543,765 - $594,951
9,787 Added 0.75%
1,306,938 $78.5 Million
Q2 2021

Aug 05, 2021

BUY
$48.42 - $60.18 $60.5 Million - $75.2 Million
1,250,180 Added 2661.6%
1,297,151 $77.7 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $161,994 - $187,001
3,435 Added 7.89%
46,971 $2.34 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $473,312 - $565,985
9,755 Added 28.88%
43,536 $2.18 Million
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $22,607 - $26,028
426 Added 1.28%
33,781 $1.85 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $440,568 - $565,378
10,222 Added 44.19%
33,355 $1.76 Million
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $369,510 - $501,904
9,778 Added 73.22%
23,133 $1.03 Million
Q4 2019

Feb 12, 2020

BUY
$42.46 - $50.46 $567,053 - $673,893
13,355 New
13,355 $666,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.